Better Outcomes For COPD Patients Related to LABAs and ICSs


A new study, entitled “Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults with Chronic Obstructive Pulmonary Disease” was published in JAMA by Andrea S. Gershon and colleagues from the Department of Medicine, Sunnybrook Health Sciences Centre and Institute for Clinical Evaluative Sciences in Toronto, Ontario, Canada. In this study, the researchers show that combination therapy with newly prescribed Long-Acting β-Agonists LABA and inhaled corticosteroid ICS was associated with a significantly lower risk of death and COPD hospitalization in older individuals with COPD, with asthma and not treated with a long-acting anticholinergic therapy when compared with newly prescribed LABAs alone.

more Better Outcomes For COPD Patients Related to LABAs and ICSs.

Print Friendly, PDF & Email